Staurosporine from Streptomyces sp.
SIGMA/S4400 - ≥98% (HPLC), film
Synonym: Staurosporine; Antibiotic AM-2282
CAS Number: 62996-74-1
Empirical Formula (Hill Notation): C28H26N4O3
Molecular Weight: 466.53
MDL Number: MFCD00077402
Linear Formula: C28H26N4O3
Product Type: Chemical
| antibiotic activity spectrum | neoplastics |
| assay | ≥98% (HPLC) |
| biological source | Streptomyces sp. |
| form | film |
| InChI | 1S/C28H26N4O3/c1-28-26(34 |
| InChI key | HKSZLNNOFSGOKW-ZGQXJOJZSA |
| mode of action | enzyme | inhibits |
| mp | 288-291 °C |
| Quality Level | 300 ![]() |
| SMILES string | CN[C@@H]1C[C@@H]2O[C@@](C |
| solubility | DMSO: soluble |
| ethanol: soluble | |
| H2O: insoluble | |
| methanol: soluble | |
| storage temp. | 2-8°C |
| Application: | Staurosporine from Streptomyces sp. was used to induce cell death in human mesenchymal stem cells and to induce cell death by PKC inhibition in hamster lung fibroblast line CCL-39. |
| Biochem/physiol Actions: | Potent inhibitor of phospholipid/calcium-depe |
| Biochem/physiol Actions: | Staurosporine from Streptomyces sp. yields clear, colorless to faint yellow solution in methanol at 2 mg/ml. |
| Features and Benefits: | This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the CDKs and InsR pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: | Chemical structure: indol derivative |
| General description: | Staurosporinefrom Streptomyces sp. is an alkaloid that induces apoptosis in a rangeof cell lines. It facilitates the inhibition of tumor cell proliferation, PKCinhibition, and blockage of cell cycle progression in various cells. Themechanisms followed by staurosporine-induced apoptosis differ among differentcell lines that include, mitochondrial apoptotic pathway, Bcl-2 overexpession,and caspase-independent mechanisms. It partially reverses multi-drug resistance (MDR), sensitizing cellswith MDR phenotype to cytotoxic agents. Staurosporine inhibits p-glycoprotein(Pgp) phosphorylation. However, the functional significance of Pgpphosphorylation is ill-defined. |
| Packaging: | 0.1, 0.5, 1 mg in serum bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H340 - H350 - H361d - H413 |
| Precautionary statements | P201 - P202 - P273 - P280 - P308 + P313 - P405 |
| Hazard Codes | T |
| Risk Statements | 45-46 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| mp | 288-291 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12161501 |


